Reveragen Biopharma Inc. Form 483 Details
Form 483Source: FDA Data DashboardFDA has published this inspection and the number of observations cited. The form itself has not been released yet, which usually takes six to twelve months.
Check this firm on FDA, establishment 3025368341Reveragen Biopharma Inc.
Rockville, Maryland, United States
Issue DateMarch 06, 2023
FEI Number3025368341
CountryUnited States
Status
No Warning LetterProduct Type
Drugs